Alphatec Spine
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Alphatec Spine sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Alphatec Spine: 7 sponsored US clinical trials, 3 recruiting.
Alphatec Spine sponsors 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting. The most-studied condition in this pipeline is Indicated for EOSedge Imaging, with 2 trials.
Upper-quartile sponsor footprint
Alphatec Spine sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
Bone Mineral Density Precision Study
NCT06830811
Bone Mineral Density Agreement Study Between EOSedge™ Versus Traditional DXA
NCT06659055
Intraoperative Monitoring for the Lateral Lumbar Interbody Fusion Procedure
NCT05648474
Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)
NCT01294007
PureGen: Radiographic Analysis of Fusion for ACDF
NCT01291134
Radiographic and Clinical Outcomes of PureGen in Posterior Lumbar (PLIF) and Transforaminal Interbody Fusion (TLIF)
NCT01293981
OsseoFix™ Spinal Fracture Reduction System in Treating Spinal Compression Fracture
NCT00961714
Therapeutic Areas
What is open in the Alphatec Spine pipeline
3 recruiting of 7 indexed (43% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Indicated for EOSedge Imaging (2 trials), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Alphatec Spine: open-pipeline peers nationwide
Peers matched on 7 registered trials and 43% open enrollment, not the therapeutic-area sidebar.
Alphatec Spine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 43% open enrollment (± trial volume)
- Clarity Pharmaceuticals · 43% recruiting · 7 trials
- Colorado Center for Reproductive Medicine · 43% recruiting · 7 trials
- David Moss · 43% recruiting · 7 trials
- EyeBiotech · 43% recruiting · 7 trials
Related
What to do with this Alphatec Spine page
7 registered trials is a research-attention snapshot, not an endorsement of Alphatec Spine or any single study.
- 3 of Alphatec Spine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Indicated for EOSedge Imaging is the condition Alphatec Spine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Indicated for EOSedge Imaging trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Alphatec Spine pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.